DYRK1A and hepatocellular carcinoma: Moreover, a small-molecule inhibitor of DYRK1 AZ191 (1 μM) that could inhibit HCC cell growth was used to treat vector or TROAP-transfected Huh7 cells (Fig. 4F and Fig. S4).